Prescription Drug Pricing

COVID-19 Solutions Fast-Tracked
Health+Benefits COVID-19 Solutions Fast-Tracked
Gilead relinquished its orphan drug status for remdesivir shortly after receivin...
May 31, 2020
Out of Reach?
Health+Benefits Out of Reach?
New models for financing and providing rare disease treatment could make for a s...
May 31, 2020
Parsing the Drug Supply Chain
Health+Benefits Parsing the Drug Supply Chain
Q&A with Eric Levin, CEO of Scripta Insights
April 27, 2020
PBGH Drug Formulary Study
Health+Benefits PBGH Drug Formulary Study
Q&A with Lauren Vela, Senior Director of Member Value, Pacific Business Group on...
March 1, 2020
Hospitals and Insurers Team Up to Manufacture Generic Drugs
Health+Benefits Hospitals and Insurers Team Up to Manufacture Generic Drugs
Unlikely advocates support lowering prescription drug costs
February 19, 2020
What Prescription Drug Importation Could Mean for Brokers
Health+Benefits What Prescription Drug Importation Could Mean for Brokers
Q&A with David Shore, SVP, Enterprise Strategy & Risk Management at Borislow Ins...
August 14, 2019
It’s Personal
Health+Benefits It’s Personal
Can insurers and PBMs harness their combined data to truly know the patient bett...
May 24, 2019
Prescription Back-Door Discounts
Health+Benefits Prescription Back-Door Discounts
Q&A with Steve Wojcik, VP, National Business Group on Health; Caleb Alexander, c...
April 19, 2019
Cloudy…with a Chance of Optimism
Industry Cloudy…with a Chance of Optimism
Blue Dogs to bipartisanship to herbal tea—The Council’s government affairs t...
January 22, 2019
Tech Giants Poised to Shift Healthcare Landscape
Health+Benefits Tech Giants Poised to Shift Healthcare Landscape
Tech companies are banging down the doors of the healthcare industry, infiltrati...
December 5, 2018